Harrogate District Hospital

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes3 trials
• Childhood cancers1 trial
• Colorectal cancer1 trial
• Diabetic eye disease1 trial
• Multiple myeloma1 trial
• Myeloproliferative neoplasms1 trial
• Obesity1 trial

Phase

• Phase 35 trials

Status

• Recruiting3 trials
• Completed2 trials
• Active, not recruiting1 trial

Lead sponsor

• Novo Nordisk A/S3 trials
• Imperial College London1 trial
• Kartos Therapeutics, Inc.1 trial
• University of Leeds1 trial

Running trials

• Recruiting

  Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  NCT06479135· Phase 3· Kartos Therapeutics, Inc.· Source

  Contact: John Mei

• Active, not recruiting

  A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes

  NCT03811561· Phase 3· Novo Nordisk A/S· Source

• Recruiting

  The Role of Ixazomib in Autologous Stem Cell Transplant in Relapsed Myeloma - Myeloma XII (ACCoRd)

  NCT03562169· Phase 3· University of Leeds· Source

  Contact: Tharani Balasubramaniam

• Recruiting

  Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers

  NCT02222844· Imperial College London· Source

  Contact: David Leinhardt

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Multiple myeloma1 recruiting
• Myeloproliferative neoplasms1 recruiting

Closed trials

• Completed

  A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight

  NCT05394519· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

  NCT03914326· Phase 3· Novo Nordisk A/S· Source